Breaking News Instant updates and real-time market news.

MDT

Medtronic

$86.28

-0.12 (-0.14%)

11:05
10/03/16
10/03
11:05
10/03/16
11:05

Medtronic Avalus shows 'positive' outcomes in one-year clinical trial results

Medtronic announced positive clinical data for its investigational Avalus pericardial aortic surgical valve, intended for the treatment of aortic valve disease. Presented at the 30th European Association for Cardio-Thoracic Surgery, or EACTS, Annual Meeting for the first time, results from the PERIGON, or PERIcardial SurGical AOrtic Valve ReplacemeNt, Pivotal Trial showed low rates of adverse valve-related events, high survival and improved hemodynamic performance at one year. One of the largest, most comprehensive and modern data sets of surgical aortic valve replacement, or SAVR, patients, the PERIGON Pivotal Trial is a single arm, non-randomized, prospective study of approximately 1,300 patients from 40 clinical sites across Europe, Canada, Japan and the United States. At one year, all patients showed low rates of all-cause mortality and cardiac death.

  • 10

    Nov

MDT Medtronic
$86.28

-0.12 (-0.14%)

08/25/16
FBCO
08/25/16
NO CHANGE
Target $92
FBCO
Outperform
Medtronic price target raised to $92 from $85 at Credit Suisse
Credit Suisse analyst Matthew Keeler raised long-term estimates for Medtronic and increased its price target to $92 to reflect the company's restated revenue reporting lines and raised its out-yer Diabetes and margin estimates. Keeler continues to see upside to shares given Medtronic's solid free cash flow, strong pipeline, and above-market topline growth. The analyst has an Outperform rating on Medtronic shares.
08/26/16
PIPR
08/26/16
NO CHANGE
PIPR
Medtronic guidance conservative, says Piper Jaffray
After Medtronic reported higher than expected Q1 EPS and in-line revenue, Piper Jaffray analyst Brooks West says the quarter was "just fine." He says that the company's failure to raise its revenue guidance to reflect recent acquisitions was conservative and "de-risks" its now "beatable" guidance. West expects new products to bolster the company's revenue, and he predicts that it will continue to gain share in CRM. He keeps a $104 price target and Overweight rating on the stock.
09/29/16
COWN
09/29/16
NO CHANGE
COWN
Outperform
Cowen says views on Dexcom, Insulet not changed by competitor launches
Cowen analyst Doug Schenkel noted that Abbott (ABT) announced yesterday it had received FDA approval for the professional version of its FreeStyle Libre glucose monitoring product and filed the consumer version of Libre, while Medtronic (MDT) also announced FDA approval of its 670G Hybrid Closed Loop system. Schenkel said Abbott's consumer Libre filing comes a few months ahead of his expectations but that Medtronic's timing was in-line with expectations. The analyst said the competitor announcements, which had been expected, do not change his views on DexCom (DXCM), Insulet (PODD), or Tandem Diabetes (TNDM) and he keeps Outperform ratings on all three of those stocks.
09/29/16
BARD
09/29/16
NO CHANGE
BARD
Dexcom, Insulet could be weighed down by competitive concerns, says Baird
Baird analyst Jeff Johnson said that while the FDA approvals announced yesterday for Abbott's (ABT) FreeStyle Libre Pro and Medtronic's (MDT) 670G were largely anticipated, he believes that both approvals came sooner than most expected, as did news that Abbott also recently filed for FDA approval of its consumer Libre system. The approvals could "change the narrative" in diabetes and could weigh on others in the sector in the near-term, most notably Dexcom (DXCM) and Insulet (PODD), Johnson tells investors. He keeps Neutral ratings on both and maintains an Overweight rating on Tandem Diabetes (TNDM), citing valuation for the difference.

TODAY'S FREE FLY STORIES

HQY

HealthEquity

$43.96

1.77 (4.20%)

, MMSI

Merit Medical

$30.85

1.25 (4.22%)

07:12
02/28/17
02/28
07:12
02/28/17
07:12
Conference/Events
BTIG to hold a conference »

Medical Technology, Life…

HQY

HealthEquity

$43.96

1.77 (4.20%)

MMSI

Merit Medical

$30.85

1.25 (4.22%)

VREX

Varex Imaging

$35.14

0.43 (1.24%)

VRAY

ViewRay

$5.71

0.95 (19.96%)

NVDQ

Novadaq

$7.49

0.18 (2.46%)

INGN

Inogen

$69.11

-0.11 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 05

    Mar

  • 06

    Mar

  • 14

    Mar

  • 22

    Mar

WRD

WildHorse Resource

$12.43

-0.15 (-1.19%)

07:12
02/28/17
02/28
07:12
02/28/17
07:12
Hot Stocks
WildHorse Resource sees 2017 daily production averaging 23-27 Mboe/d »

2017 Financial and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 05

    Mar

SGMO

Sangamo

$4.30

0.3 (7.50%)

07:11
02/28/17
02/28
07:11
02/28/17
07:11
Earnings
Sangamo sees FY17 revenue $14M-$19M, consensus $22.51M »

Sees FY17 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 27

    Apr

07:11
02/28/17
02/28
07:11
02/28/17
07:11
Conference/Events
JPMorgan to hold a conference »

Investment Companies…

JD

JD.com

$30.80

0.53 (1.75%)

07:11
02/28/17
02/28
07:11
02/28/17
07:11
Recommendations
JD.com analyst commentary  »

JD.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

PCLN

Priceline

$1,632.01

0.39 (0.02%)

07:11
02/28/17
02/28
07:11
02/28/17
07:11
Recommendations
Priceline analyst commentary  »

Priceline price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANF

Can-Fite BioPharma

$1.96

0.0024 (0.12%)

07:11
02/28/17
02/28
07:11
02/28/17
07:11
Hot Stocks
Can-Fite BioPharma: Data show Namodenoson prevents liver fibrosis progression »

Can-Fite BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WRD

WildHorse Resource

$12.43

-0.15 (-1.19%)

07:11
02/28/17
02/28
07:11
02/28/17
07:11
Hot Stocks
WildHorse Resource reports year-end 2016 proved reserves of 152.5MMboe »

Year-End 2016 Reserves:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 05

    Mar

I

Intelsat

$5.87

1.18 (25.16%)

07:11
02/28/17
02/28
07:11
02/28/17
07:11
Earnings
Intelsat sees 2017 revenue $2.18B-$2.225B, consensus $2.16B »

Intelsat forecasts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Conference/Events
KeyBanc to hold a summit »

Emerging Technology…

SAR

Saratoga Investment

$22.22

-0.63 (-2.76%)

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Hot Stocks
Saratoga Investment raises quarterly dividend to 46c per share »

Saratoga Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMO

Sangamo

$4.30

0.3 (7.50%)

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Earnings
Sangamo reports Q4 EPS (14c), consensus (25c) »

Reports Q4 revenue $8.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 27

    Apr

I

Intelsat

$5.87

1.18 (25.16%)

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Earnings
Intelsat reports Q4 EPS $5.56 vs. ($38.29) last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

CAT

Caterpillar

$97.44

1.96 (2.05%)

, ITW

Illinois Tool Works

$131.88

0.2 (0.15%)

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Conference/Events
Evercore ISI to hold a conference »

Annual Industrials…

CAT

Caterpillar

$97.44

1.96 (2.05%)

ITW

Illinois Tool Works

$131.88

0.2 (0.15%)

URI

United Rentals

$128.21

4.06 (3.27%)

KMT

Kennametal

$37.71

0.08 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 07

    Mar

  • 07

    Mar

  • 14

    Jun

PRXL

PAREXEL

$66.26

0.32 (0.49%)

, GSK

GlaxoSmithKline

$41.57

0.01 (0.02%)

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Hot Stocks
PAREXEL names SImon Harford as SVP, CFOG »

PAREXEL International…

PRXL

PAREXEL

$66.26

0.32 (0.49%)

GSK

GlaxoSmithKline

$41.57

0.01 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 14

    Mar

07:09
02/28/17
02/28
07:09
02/28/17
07:09
Conference/Events
Credit Suisse to hold a conference »

2017 Global Healthcare…

IONS

Ionis Pharmaceuticals

$46.90

2.31 (5.18%)

07:09
02/28/17
02/28
07:09
02/28/17
07:09
Earnings
Ionis Pharma reports Q4 GAAP EPS 21c, may not compare with consensus (12c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

SAR

Saratoga Investment

$22.22

-0.63 (-2.76%)

07:09
02/28/17
02/28
07:09
02/28/17
07:09
Hot Stocks
Saratoga Investment raises quarterly dividend to 46c per share »

Saratoga Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDCO

The Medicines Co.

$53.22

1.16 (2.23%)

07:08
02/28/17
02/28
07:08
02/28/17
07:08
Earnings
The Medicines Co. reports Q4 adjusted EPS ($1.19), consensus ($1.43) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

FEYE

FireEye

$11.50

0.26 (2.31%)

, PI

Impinj

$29.12

-0.87 (-2.90%)

07:08
02/28/17
02/28
07:08
02/28/17
07:08
Conference/Events
Pacific Crest to hold a summit »

12th Annual Pacific Crest…

FEYE

FireEye

$11.50

0.26 (2.31%)

PI

Impinj

$29.12

-0.87 (-2.90%)

BL

BlackLine

$29.56

-0.36 (-1.20%)

FB

Facebook

$136.41

0.97 (0.72%)

MB

MINDBODY

$27.05

1.1 (4.24%)

PCTY

Paylocity

$36.41

-0.37 (-1.01%)

AZPN

Aspen Technology

$59.00

0.63 (1.08%)

ECOM

ChannelAdvisor

$10.75

-0.4 (-3.59%)

DATA

Tableau

$53.58

0.32 (0.60%)

CTXS

Citrix

$80.16

-0.02 (-0.02%)

GRPN

Groupon

$4.49

0.02 (0.45%)

CYBR

CyberArk

$50.60

0.07 (0.14%)

PFPT

Proofpoint

$79.35

-0.29 (-0.36%)

WDAY

Workday

$90.19

0.53 (0.59%)

ULTI

Ultimate Software

$199.17

0.81 (0.41%)

AMBR

Amber Road

$7.75

-0.1 (-1.27%)

VEEV

Veeva

$44.14

-0.07 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 09

    Mar

  • 10

    Mar

  • 13

    Mar

  • 14

    Mar

  • 19

    Mar

  • 22

    Mar

  • 23

    Mar

  • 24

    Mar

  • 28

    Mar

SXL

Sunoco Logistics

$25.23

-0.04 (-0.16%)

07:08
02/28/17
02/28
07:08
02/28/17
07:08
Initiation
Sunoco Logistics initiated  »

Sunoco Logistics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDAY

Workday

07:08
02/28/17
02/28
07:08
02/28/17
07:08
Downgrade
Workday rating change  »

Workday downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 13

    Mar

  • 14

    Mar

NXST

Nexstar

$70.20

0.45 (0.65%)

07:07
02/28/17
02/28
07:07
02/28/17
07:07
Earnings
Nexstar reports Q4 EPS 64c including items, consensus $1.38 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 06

    Mar

VRX

Valeant

$16.71

0.53 (3.28%)

07:07
02/28/17
02/28
07:07
02/28/17
07:07
Hot Stocks
Valeant CEO says 'well poised for turnaround in 2017' »

"Today, we announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 02

    Mar

  • 14

    Mar

ROYT

Pacific Coast Oil

$1.94

0.02 (1.04%)

07:07
02/28/17
02/28
07:07
02/28/17
07:07
Downgrade
Pacific Coast Oil rating change  »

Pacific Coast Oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.